Liftstream is an executive search recruitment company in the life sciences sector
Companies to partner executive search firms which have elevated their D&I expertise, and explicitly request increased candidate diversity.
Engaging talented leaders is an issue facing the biotech industry in almost any life sciences cluster you care to look. At the executive level competition for CEOs, R&D, Finance, Medical and BD executives is fierce, but equally so at the board level, the search for talent is far-reaching. This search for talent is acutely felt in Cambridge, Massachusetts, where Kendall Square has become a battle ground for high caliber leaders, spilling out to companies throughout the wider Boston and Massachusetts vicinity.
Immunocore, a biotechnology company developing novel T cell receptor (TCR) based biological drugs to treat cancer, viral infections and autoimmune disease, has appointed James Sandy as Chief Development Officer and Julian Hirst as Director of Corporate Finance. These new positions will be based in the firm’s headquarter in Oxford, UK.
F-star, a biopharmaceutical company developing novel bispecific antibodies with a focus on immuno-oncology, has appointed of Dr Neil Brewis as Chief Scientific Officer.
Aegerion has faced increasing investor pressure of late, with a barrage of hostilities from activist investor, Alex Denner. He won a breakthrough earlier this year when a standstill agreement was reached with the board and CEO, Marc Beer, to nominate an independent board director for his investment firm Sarissa Capital Management, installing Jorge Plutzky as the nominated independent director . Denner is a former investor with Carl Icahn, also famed for his aggressive investor activism and ability to use corporate governance to enforce change.